US 11932705
Cyclic polypeptides for PCSK9 inhibition
granted A61KA61K38/00
Quick answer
US patent 11932705 (Cyclic polypeptides for PCSK9 inhibition) held by RA PHARMACEUTICALS, INC. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00